Papers in peer-reviewed scientific journals.
|
|
- Piers George
- 6 years ago
- Views:
Transcription
1 2013 Papers in peer-reviewed scientific journals. Al Jumah M, Al Khathaami A, Tamim H, Al Owayed A, Kojan S, Jawhary A, Lipton R, Buse D, Jensen R, Steiner T HURT (Headache Under-Response to Treatment) questionnaire in the management of primary headache disorders: reliability, validity and clinical utility of the Arabic version. J Headache Pain Feb 21;14(1): Amin FM, Asghar MS, Ravneberg JW, de Koning PJH, Larsson HBW, Olesen J, et al. The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers. Cephalalgia 2013 Sep;33(12): Amin FM, Asghar MS, Hougaard A, Hansen AE, Larsen VA, de Koning PJH, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurology 2013 May;12(5): Antonova M, Wienecke T, Olesen J, Ashina M. Prostaglandins in migraine: update. Current Opinion in Neurology 2013 Jun;26(3): Ashina M, Hansen JM, Olesen J. Pearls and pitfalls in human pharmacological models of migraine: 30 years experience. Cephalalgia 2013 Jun;33(8): Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain A systematic review and meta-analysis. Neurology 2013 Oct 1;81(14): Bhatt DK, Gupta S, Jansen-Olesen I, Andrews JS, Olesen J. NXN-188, a selective nnos inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models. Cephalalgia 2013 Jan;33(2): Esserlind AL, Christensen AF, Le H, Kirchmann M, Hauge AW, Toyserkani NM, et al. Replication and meta-analysis of common variants identifies a genome-wide significant
2 locus in migraine. European Journal of Neurology 2013 May;20(5): Guo S, Ashina M, Olesen J, Birk S. The effect of sodium nitroprusside on cerebral hemodynamics and headache in healthy subjects. Cephalalgia 2013 Apr;33(5): Guo S, Olesen J, Ashina M, Birk S. The effect of sodium nitroprusside on cerebral haemodynamic and headache in healthy subjects. Journal of Headache and Pain 2013 Feb;14. Henriksen OM, Kruuse C, Olesen J, Jensen LT, Larsson HBW, Birk S, et al. Sources of variability of resting cerebral blood flow in healthy subjects: a study using Xe-133 SPECT measurements. Journal of Cerebral Blood Flow and Metabolism 2013 May;33(5): Hougaard A, Amin F, Hauge AW, Ashina M, Olesen J. Provocation of migraine with aura using natural trigger factors. Neurology 2013 Jan;80(5): Jansen-Olesen I, Tfelt-Hansen P, Olesen J. Animal Migraine Models for Drug Development: Status and Future Perspectives. Cns Drugs 2013 Dec;27(12): Jensen R, Tfelt-Hansen P. [The most important question in diagnosing cluster headache is the duration of the extremely severe headache]. Ugeskr Laeger 2013 Feb 4;175(6): Martelletti P, Jensen HR, Antal A, Arcioni R, Brighina F, de Tommaso M, Franzini A, Fontaine D, Heiland M, Jürgens P T, Leone M, Magis D, Paemeleire K, Palmisani S, Paulus W, May A. Neuromodulation of chronic headaches: position statement from the European Headache Federation.J Headache Pain.2013, 14:86. Munksgaard SB, Bendtsen L, Jensen RH. Modulation of central sensitisation by detoxification in MOH: Results of a 12-month detoxification study. Cephalalgia 2013
3 May;33(7): Munksgaard SB, Ashina M. [Events in the Danish Headache Society in 2012]. Ugeskr Laeger Mar 18;175(12):798. Olesen J, Lebedeva E. Comment on Headache Following Intracranial Neuroendovascular Procedures. Headache 2013 Feb;53(2): Olesen J. Ten-year anniversary of the European Brain Council The major achievements. European Journal of Neurology 2013 Apr;20(4): Olesen J. ICHD-3 beta is published. Use it immediately. Cephalalgia 2013 Jul;33(9): Pedersen JL, Barloese M, Jensen RH. Neurostimulation in cluster headache: a review of current progress. Cephalalgia 2013 Oct;33(14): Phillip D, Iversen HK, Schytz HW, Selb J, Boas DA, Ashina M. Altered Low Frequency Oscillations of Cortical Vessels in Patients with Cerebrovascular Occlusive Disease - A NIRS Study. Front Neurol Dec 16;4:204. Schoenen J, Jensen RH, Lanteri-Minet M, Lainez MJA, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study. Cephalalgia 2013 Jul;33(10): Schytz HW, Barlose M, Guo S, Selb J, Caparso A, Jensen R, et al. Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans. Cephalalgia 2013 Jul;33(10): Schytz HW, Jensen BE, Jennum P, Selb J, Boas DA, Ashina M. Low-frequency oscillations and vasoreactivity of cortical vessels in obstructive sleep apnea during
4 wakefulness: A near infrared spectroscopy study. Sleep Medicine 2013 May;14(5): Schytz HW, Guo S, Jensen LT, Kamar M, Nini A, Gress DR, et al. Monitoring changes in cerebral blood flow using ultrasound tagged near infrared spectroscopy - A comparative study to 133Xe SPECT. Cerebrovascular Diseases 2013;35:45-6. Shah AM, Bendtsen L, Zeeberg P, Jensen RH. Reduction of Medication Costs After Detoxification for Medication- Overuse Headache. Headache 2013 Apr;53(4): Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 2013 Feb;251(2): Steiner TJ, Stovner LJ, Al Jumah M, Birbeck GL, Gururaj G, Jensen R, Katsarava Z, Queiroz LP, Scher AI, Tekle- Haimanot R, Wang SJ, Martelletti P, Dua T, Chatterji S.Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations. J Headache Pain Oct 25;14(1):87. Tfelt-Hansen P. Official Treatment Guidelines in Migraine Treatment Should Be like Caesar s Wife. A Critical Review of the Content and Practical Consequences of 3 Recent Guidelines for Migraine Prevention. Cephalalgia 2013 Jun;33(S8): Tfelt-Hansen P, Hougaard A. Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine. Expert Opinion on Drug Metabolism & Toxicology 2013 Jan;9(1): Tfelt-Hansen PC. Relatively slow and long-lasting antimigraine effect of dihydroergotamine is most likely due to basic pharmacological attributes of the drug: A review. Cephalalgia 2013 Oct;33(13):
5 Tfelt-Hansen PC. Triptans and ergot alkaloids in the acute treatment of migraine: similarities and differences. Expert Review of Neurotherapeutics 2013 Sep;13(9): Tfelt-Hansen PC. The Efficacy of Transdermal Sumatriptan Is Too Low for General Use in Migraine. Headache 2013 May;53(5): Tfelt-Hansen PC. Evidence-Based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2013 Feb;80(9): Tornoe B, Andersen LL, Skotte JH, Jensen R, Gard G, Skov L, et al. Test-retest repeatability of strength capacity, aerobic power and pericranial tenderness of neck and shoulder muscles in children - relevant for tension-type headache. J Pain Res 2013;6: Westergaard MLS, Steiner TJ, MacGregor EA, Antonaci F, Tassorelli C, Buse DC, et al. The Headache Under-Response to Treatment (HURT) Questionnaire: Assessment of utility in headache specialist care. Cephalalgia 2013 Mar;33(4): Westergaard ML, Hansen EH, Glümer C, Olesen J, Jensen RH. Definitions of medication-overuse headache in population- based studies and their implications on prevalence estimates: A systematic review. Cephalalgia Nov 29. [Epub ahead of print]. Wilbrink LA, Teernstra OP, Haan J, van Zwet EW, Evers SM, Spinc le GH, Veltink PH, Mulleners W, Brand R, Huygen FJ, Jensen RH, Paemeleire K, Goadsby PJ, Visser-Vandewalle V, Ferrari MD. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia 2013;33:
Papers in peer-reviewed scientific journals.
2012 Papers in peer-reviewed scientific journals. Amin FM, Asghar MS, Guo S, Hougaard A, Hansen AE, Schytz HW et al. Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy
More informationClinical Commissioning Policy Statement: Sphenopalatine Ganglion Stimulation for Refractory Chronic Cluster Headache (Adults)
Clinical Commissioning Policy Statement: Sphenopalatine Ganglion Stimulation for Refractory Chronic Cluster Headache (Adults) NHS England Reference: 170083P 1 Contents 1. Plain Language Summary... 3 2.
More informationMedication overuse headache: a critical review of end points in recent follow-up studies
J Headache Pain (2010) 11:373 377 DOI 10.1007/s10194-010-0221-4 REVIEW ARTICLE Medication overuse headache: a critical review of end points in recent follow-up studies Knut Hagen Rigmor Jensen Magne Geir
More informationAl Jumah et al. The Journal of Headache and Pain 2013, 14:16
Al Jumah et al. The Journal of Headache and Pain 2013, 14:16 RESEARCH ARTICLE Open Access HURT (Headache Under-Response to Treatment) questionnaire in the management of primary headache disorders: reliability,
More informationEpidemiology and Burden of Headache
D A N I S H H E A D A C H E C E N T E R Epidemiology and Burden of Headache EHF Headache Summer school in Belgrade Rigmor Hoejland Jensen, Professor, Dr.Med.Sci., Danish Headache Center, Department of
More informationOveruse of barbiturate and opioid containing medications for primary headache disorders Description
Measure Title Overuse of barbiturate and opioid containing medications for primary headache disorders Description Percentage of s age 12 years and older with a diagnosis of primary headache who were prescribed
More informationMIGRAINE ASSOCIATION OF IRELAND
MIGRAINE ASSOCIATION OF IRELAND HEADACHE IN MEN: THE FACTS This leaflet was composed by Paolo Rossi M.D., Ph.D. of the European Headache Alliance to mark European Migraine Day of Action 2014. Why a leaflet
More informationANTIMIGRAINE MEDICINES
1 07.00.00.00 - ANTIMIGRAINE MEDICINES 1. Summary statement For acute migraine therapy the following new medicine is proposed: Sumatriptan 50 mg. 2. 3. Global Campaign to Reduce the Burden of Headache
More informationThe epidemiology of headache disorders: a face-to-face interview of participants in HUNT4
Hagen et al. The Journal of Headache and Pain (2018) 19:25 https://doi.org/10.1186/s10194-018-0854-2 The Journal of Headache and Pain RESEARCH ARTICLE The epidemiology of headache disorders: a face-to-face
More informationPrednisone vs. placebo in withdrawal therapy following medication overuse headache
doi:10.1111/j.1468-2982.2007.01488.x Prednisone vs. placebo in withdrawal therapy following medication overuse headache L Pageler 1,2, Z Katsarava 2, HC Diener 2 & V Limmroth 1,2 1 Department of Neurology,
More informationA New Era of Migraine Management: The Challenging Landscape in Prevention
Provided by MediCom Worldwide, Inc. Supported by an educational grant from Teva Pharmaceuticals What is a Neuropeptide? Small chains of amino acids released by neural cells (neurons or glial cells) to
More informationPosterior Cerebral Hypoperfusion in Migraine without Aura Marie Denuelle, MD Neurology Service, Rangueil Hospital Toulouse, France
Posterior Cerebral Hypoperfusion in Migraine without Aura Marie Denuelle, MD Neurology Service, Rangueil Hospital Toulouse, France Most of the cerebral blood flow (CBF) studies in migraine have introduced
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationOnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study The Harvard community has made this article openly available. Please share how this access benefits you. Your story
More informationMeasurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiography
Amin et al. The Journal of Headache and Pain 2014, 15:25 RESEARCH ARTICLE Open Access Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance
More informationRefractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation Mitsikostas, Dimos D.; Edvinsson, Lars; Jensen, Rigmor H.; Katsarava, Zaza; Lampl,
More information12 th. European Headache Federation Congress September 2018 Florence Palazzo dei Congressi.
12 th European Headache Federation Congress 28-30 September 2018 Florence Palazzo dei Congressi www.ehf2018.com 1 Friday, 28 September 2018 07:00-08:00 REGISTRATION 08:00-09:00 INDUSTRY SPONSORED SESSION
More informationRISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE
RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE Gretchen E. Tietjen, MD University of Toledo Toledo, Ohio Learning objectives At the conclusion of this presentation, participants should be able to: 1. Understand
More informationPublikationer Liste af Publikationer
Publikationer Liste af Publikationer The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine Al-Karagholi, M. A-M., Hansen, J. M., Severinsen, J., Jansen-Olesen, I. & Ashina,
More informationHEADACHE PATHOPHYSIOLOGY
HEADACHE PATHOPHYSIOLOGY Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research and Treatment
More informationSpecific Objectives A. Topics to be lectured and discussed at the plenary sessions
Specific Objectives A. Topics to be lectured and discussed at the plenary sessions 0. Introduction: Good morning ICHD-III! Let s start at the very beginning. When you read you begin with A-B-C, so when
More informationWhat is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary
What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary Overview Understanding the burden Commonly used terms Acute therapy What we currently have What we are going
More informationMEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache
MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache Measure Description Percentage of patients age 18 years old and older with a diagnosis of primary headache
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition Joint Session with ACOFP, ACONP and AOAAM:
More informationTreatment Of Medication. Overuse Headache
7 November 2012 BASH GPwSI Meeting Lecture title... Treatment Of Medication Dr... Overuse Headache Dr Marcus Lewis Dr... The National Migraine Centre International Headache Society Diagnostic criteria
More informationA new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results
J Headache Pain (2004) 5:S112 S116 DOI 10.1007/s10194-004-0123-4 Michele Feleppa Fred D. Sheftell Luciana Ciannella Amedeo D Alessio Giancarlo Apice Nino N. Capobianco Donato M.T. Saracino Walter Di Iorio
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 8 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationMultidisciplinary team approach to headache care
Review Multidisciplinary team approach to headache care Rigmor Højland Jensen* & Annette Rasmussen Practice Points So-called refractory headache patients may be difficult to treat but are far from intractable.
More informationDespite the widespread use of triptans ... REPORTS... Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability
... REPORTS... Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability Randal L. Von Seggern, PharmD, BCPS Abstract Objective: This article summarizes preclinical and clinical data for
More informationHeadache: Using Neuromodulation as Therapy
Headache: Using Neuromodulation as Therapy Rashmi Halker, MD, FAHS Assistant Professor of Neurology Department of Neurology Mayo Clinic Phoenix Arizona Disclosures Nothing to disclose 2013 MFMER slide-2
More informationField testing of the ICHD-3β and expert opinion criteria for chronic migraine
Jiang et al. The Journal of Headache and Pain (2016) 17:85 DOI 10.1186/s10194-016-0678-x The Journal of Headache and Pain RESEARCH ARTICLE Open Access Field testing of the ICHD-3β and expert opinion criteria
More information10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD
Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen
More informationDavid W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA
Headache Masters School 2013 in Asia Sunday March 24, 2013 Procedural Medicine Workshop Onabotulinumtoxin A: Evidence, Injection Technique, and Mechanism of Action David W. Dodick M.D. Professor Director
More informationThe validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study
J Headache Pain (2010) 11:67 73 DOI 10.1007/s10194-009-0174-7 ORIGINAL The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study 2006 2008 Knut Hagen John-Anker Zwart Anne Hege
More informationSphenopalatine Ganglion Stimulation in Neurovascular Headaches
Slavin V (ed): Stimulation of the Peripheral Nervous System. The Neuromodulation Frontier. Prog Neurol Surg. Basel, Karger, 2016, vol 29, pp 106 116 ( DOI: 10.1159/000434661 ) Sphenopalatine Ganglion Stimulation
More informationMeasure Components Numerator Statement
MEASURE #5: OVERUSE OF OPIOID CONTAINING MEDICATIONS FOR PRIMARY HEADACHE DISORDERS Headache For Quality Improvement Only. Not to be used for Public Reporting or Accountability Measure Description Percentage
More informationHeadache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden attributable to headache disorders
Ayzenberg et al. The Journal of Headache and Pain 2015, 16:7 RESEARCH ARTICLE Open Access Headache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More informationOccipital Nerve Stimulation with the Bion Microstimulator for the Treatment of Medically Refractory Chronic Cluster Headache
Pain Physician 2011; 14:435-440 ISSN 1533-3159 Case Report Occipital Nerve Stimulation with the Bion Microstimulator for the Treatment of Medically Refractory Chronic Cluster Headache Natalie H. Strand
More informationOccipital Nerve Stimulation Corporate Medical Policy
Occipital Nerve Stimulation Corporate Medical Policy File Name: Occipital Nerve Stimulation File Code: UM.SPSVC.14 Origination: 2011 Last Review: 06/2018 Next Review: 06/2019 Effective Date: 10/01/2018
More informationAleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia
European Headache School Belgrade 2012 MEDICATION OVERUSE HEADACHE Aleksandra Radojičić Headache Center, Neurology Clinic, Clinical Center of Serbia Historical data First cases were described in XVII century
More informationSupraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy)
NEUROSTIMULATION/NEUROMODULATION UPDATE Meyer and Renee Luskin Andrew Charles, M.D. Professor Luskin Chair in Migraine and Headache Studies Director, UCLA Goldberg Migraine Program David Geffen School
More informationElena R Lebedeva 1, Jes Olesen 2, Vera V Osipova 3, Larisa I Volkova 1, Guzyal R Tabeeva 3 and Timothy J Steiner 4*
Lebedeva et al. The Journal of Headache and Pain 2013, 14:101 METHODOLOGY Open Access The Yekaterinburg headache initiative: an interventional project, within the Global Campaign against Headache, to reduce
More informationManagement of headache
Management of headache TJ Steiner Imperial College London Based on European principles of management of common headache disorders TJ Steiner, K Paemeleire, R Jensen, D Valade, L Savi, MJA Lainez, H-C Diener,
More informationCongratulations on getting hold of Become a therapist who can consistently solve chronic headaches 10 steps.
Hey there, Congratulations on getting hold of Become a therapist who can consistently solve chronic headaches 10 steps. Now I can tell you from experience that if you can get lasting outcomes for patients
More informationPDFlib PLOP: PDF Linearization, Optimization, Protection. Page inserted by evaluation version
PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version www.pdflib.com sales@pdflib.com Headache 2008 the Authors Journal compilation 2008 American Headache Society
More informationComorbidities of Migraine
Comorbidities of Migraine Richard B. Lipton, MD Edwin S Lowe Professor and Vice Chair of Neurology Director, Montefiore Headache Center Albert Einstein College of Medicine Overview What is comorbidity?
More informationHeadache A Practical Approach
Headache A Practical Approach Integrated Pain Symposium December 1, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache and Pain Development Teams Disclosures:
More informationMedication overuse headache is a severe chronic pain condition that is preventable and treatable. An International Experience
Medication overuse headache is a severe chronic pain condition that is preventable and treatable An International Experience C. Tassorelli Chair of Neurolgy, Department of Brain and Behavioral Sciences,
More informationThe use of combination therapies in the acute management of migraine
REVIEW The use of combination therapies in the acute management of migraine Abouch Valenty Krymchantowski Headache Center of Rio, Rio de Janeiro, Brazil; Outpatient Headache Unit of the Instituto de Neurologia
More informationHEADACHE & FACIAL PAIN SECTION. Review Article Neurostimulation for Treatment of Migraine and Cluster Headache
Pain Medicine 2015; 16: 1827 1834 Wiley Periodicals, Inc. HEADACHE & FACIAL PAIN SECTION Review Article Neurostimulation for Treatment of Migraine and Cluster Headache Todd J. Schwedt, MD,* and Bert Vargas,
More informationDoes analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
DOI 10.1186/s40064-015-1386-8 RESEARCH Open Access Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse Fayyaz Ahmed *, Hassan
More informationPREVALENCE BY HEADACHE TYPE
CLINICAL CLUES AND CLINICAL RULES: PRIMARY VS SECONDARY HEADACHE * Based on a presentation by David W. Dodick, MD ABSTRACT Headache is a common condition, accounting for many specialist office visits annually.
More informationIs the Migraid device an asset in the non-pharmacologic treatment of migraine?
Acta neurol. belg., 2007, 107, 40-46 Is the Migraid device an asset in the non-pharmacologic treatment of migraine? Herman PIETERSE 1,3, Joop A. M. KUSTER 2 and Luc M. VAN BORTEL 1 1 Heymans Institute
More informationNeurostimulation 2016
Neurostimulation 2016 Stephen D Silberstein, MD Jefferson Headache Center Thomas Jefferson University Hospital Philadelphia, PA 1 Neuromostimulation Occipital Nerve Stimulation (ONS) Transcranial Magnetic
More informationA two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
Negro et al. The Journal of Headache and Pain (2016) 17:1 DOI 10.1186/s10194-016-0591-3 RESEARCH ARTICLE A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache:
More informationACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli
The European Headache School 2012 ACUTE TREATMENT FOR MIGRAINE Cristina Tassorelli Headache Science Centre, IRCCS Neurological Institute C. Mondino Foundation - Pavia University Centre for Adaptive Disorders
More informationMigraine - whats on the horizon
Managing your migraine Edinburgh Saturday 10 th March 2018 Migraine - whats on the horizon Alok Tyagi Consultant Neurologist Glasgow Disclaimer I have received from Janssen Cillag, GSK, Allergan, Electrocore,
More informationHeadache disorders and public ill-health in India: prevalence estimates in Karnataka State
Kulkarni et al. The Journal of Headache and Pain (215) 16:67 DOI 1.1186/s1194-15-549-x RESEARCH ARTICLE Open Access Headache disorders and public ill-health in India: prevalence estimates in Karnataka
More informationGenetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
J Headache Pain (2010) 11:431 435 DOI 10.1007/s10194-010-0241-0 RAPID COMMUNICATION Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine Giovanna Gentile Marina Borro Noemi
More informationTimetable. Friday, 1 December Sala Sinopoli. Teatro Studio REGISTRATION EHF SCHOOL FOR ADVANCED STUDIES SPONSORED SYMPOSIUM
Timetable Friday, 1 December 2017 Sala Sinopoli Teatro Studio 07.00-08.00 REGISTRATION 08.00-09.00 EHF SCHOOL FOR ADVANCED STUDIES 09.00-10.00 HEADACHE IN EUROPE: EHF MEETS EFIC SPECIAL CORNER 10.00-11.00
More informationThe PACAP Receptor: A Novel Target for Migraine Treatment
DEPARTMENT OF NEUROLOGY D A N I& S DANISH H H E AHEADACHE D A C H E CENTER C E N T E R Faculty of Health and Medical Sciences The PACAP Receptor: A Novel Target for Migraine Treatment Messoud Ashina, MD,
More informationASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION
Acta Medica Mediterranea, 2014, 30: 1007 ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION E. ESRA OKUYUCU*, OGUZ GUVEN**, EDIP UCAR***, TASKIN DUMAN*
More informationOnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
Pedraza et al. SpringerPlus (2015) 4:176 DOI 10.1186/s40064-015-0957-z a SpringerOpen Journal RESEARCH Open Access OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with
More informationComparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
Grände et al. The Journal of Headache and Pain 2014, 15:22 RESEARCH ARTICLE Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds Gustaf
More informationMigraine much more than just a headache
Migraine much more than just a headache Session hosted by Teva UK Limited PUU4 11:15 12:15 UK/NHSS/18/0021b Date of Preparation: August 2018 The views expressed in this presentation are those of the speaker
More informationThe Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research
Steiner and Lipton The Journal of Headache and Pain (2018) 19:12 DOI 10.1186/s10194-018-0837-3 The Journal of Headache and Pain METHODOLOGY Open Access The Headache-Attributed Lost Time (HALT) Indices:
More informationMigraine Diagnosis and Treatment: Results From the American Migraine Study II
Migraine Diagnosis and Treatment: Results From the American Migraine Study II Richard B. Lipton, MD; Seymour Diamond, MD; Michael Reed, PhD; Merle L. Diamond, MD; Walter F. Stewart, MPH, PhD Objective.
More informationCalcitonin Gene-Related Peptide as a Biomarker in Migraine
Original Article J Neurol Res. 2017;7(6):103-107 Calcitonin Gene-Related Peptide as a Biomarker in Migraine Aktham Ismail Alemam a, b, Wafeek Mahmoud Alsheikh a, Ibrahim Alsayed Alahmar a Abstract Background:
More informationPhysical exercise and migraine: for or against?
Column in Laboratory Medicine Page 1 of 6 Physical exercise and migraine: for or against? Giuseppe Lippi 1, Camilla Mattiuzzi 2, Fabian Sanchis-Gomar 3,4 1 Section of Clinical Biochemistry, University
More informationThe burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State
Rao et al. The Journal of Headache and Pain (2015) 16:94 DOI 10.1186/s10194-015-0574-9 RESEARCH ARTICLE Open Access The burden attributable to headache disorders in India: estimates from a community-based
More informationRecommendations for headache service organisation and delivery in Europe
J Headache Pain (2011) 12:419 426 DOI 10.1007/s10194-011-0320-x ORIGINAL Recommendations for headache service organisation and delivery in Europe T. J. Steiner F. Antonaci R. Jensen M. J. A. Lainez M.
More informationAnnual Report. Headache Center. Department of Neurology Glostrup Hospital, University of Copenhagen.
Annual Report Danish 2010 Headache Center Department of Neurology Glostrup Hospital, University of Copenhagen www.danishheadachecenter.dk Baseline After CGRP After Sumatriptan Table of contents 1. Research...2
More informationAdvances in the Treatment of Migraine
Advances in the Treatment of Migraine C. Philip O Carroll, M.D. Director Neurobehavioral Medicine Hoag Neurosciences Institute Guyuron B Headache, 2015;55:1464-1473 I m sorry your head hurts, sweetie.is
More informationMigraine attacks in the pharmacy: a survey in Piedmont, Italy
DOI 10.1007/s10072-014-1733-5 FICEF SYMPOSIUM - HEADACHE IN THE FRONT LINE: FROM PHARMACIST TO GENERAL PRACTITIONER Migraine attacks in the pharmacy: a survey in Piedmont, Italy P. Brusa G. Allais G. Bussone
More information11/10/2017. Headache and Increased Pressure: A tale of 2 cases. Kathleen Digre MD University of Utah TWO CASES. 23 yo medical practice manager
Headache and Increased Pressure: A tale of 2 cases Kathleen Digre MD University of Utah TWO CASES 23 yo medical practice manager September 2016 began developing intense frontal headaches first intermittent
More informationValue of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example
J Headache Pain (2006) 7:27 33 DOI 10.1007/s10194-006-0266-6 ORIGINAL Julio Pascual Hans-Christoph Diener Hélène Massiou Value of postmarketing surveillance studies in achieving a complete picture of antimigraine
More informationMigraine Research Update Clinical and Scientific Highlights. David W. Dodick M.D. Professor Department of Neurology Mayo Clinic Phoenix Arizona
Migraine Research Update Clinical and Scientific Highlights David W. Dodick M.D. Professor Department of Neurology Mayo Clinic Phoenix Arizona 1 Objective Discuss some of the important advances in clinical
More informationEuropean Headache Federation Executive Committee Meeting 12 th December, :30 17:30 Vienna, Austria MINUTES
European Headache Federation Executive Committee Meeting 12 th December, 2014 11:30 17:30 MINUTES Attending members: Dr. Mitsikostas, Dr. Osipova, Dr. Jensen, Dr. Katsarava, Dr. Martelletti, Dr. Lampl,
More informationSafety and efficacy of cervical 10 khz spinal cord stimulation in chronic refractory primary headaches: a retrospective case series
Lambru et al. The Journal of Headache and Pain (2016) 17:66 DOI 10.1186/s10194-016-0657-2 The Journal of Headache and Pain SHORT REPORT Open Access Safety and efficacy of cervical 10 khz spinal cord stimulation
More informationRegulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: November 30, 2018 Migranal Nasal Spray
More informationMigraine Management. Roger Cady, MD Headache Care Center Springfield, MO
Migraine Management Roger Cady, MD Headache Care Center Springfield, MO Disclosures Objectives The evolution of migraine From benign episodic (benign) headache to potentially a devastating chronic disease
More informationInterictal burden attributable to episodic headache: findings from the Eurolight project
Lampl et al. The Journal of Headache and Pain (2016) 17:9 DOI 10.1186/s10194-016-0599-8 RESEARCH ARTICLE Open Access Interictal burden attributable to episodic headache: findings from the Eurolight project
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 05.70.10 Subject: Sumatriptan Page: 1 of 5 Last Review Date: December 2, 2016 Sumatriptan Description Sumatriptan
More informationOccipital Nerve Stimulation
Occipital Nerve Stimulation Policy Number: 7.01.125 Last Review: 5/2018 Origination: 5/2006 Next Review: 5/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage for
More informationTension-type headache Comorbidities EHF-summerschool Belgrade May 2012
Tension-type headache Comorbidities EHF-summerschool Belgrade May 2012 Conflicts of Interest: Lectures for Pfizer, Berlin-Chemie, Allergan, Merck Member of advisory boards in: ATI, Medotech, Neurocore,
More informationClinical Learning Days November 10, 2017
Migraine Clinical Learning Days November 10, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache Disclosures: none Learning Objectives: At the conclusion
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 0 Subject: Sumatriptan Page: 1 of 6 Last Review Date: November 30, 2018 Sumatriptan Description Sumatriptan
More information23 How Cluster Headache and Other Trigeminal Autonomic Cephalalgias Present
23 How Cluster Headache and Other Trigeminal Autonomic Cephalalgias Present Henrik Winther Schytz 1. Cristina Tassorelli 2. Messoud Ashina 1 1 Glostrup Hospital, University of Copenhagen, Glostrup, Copenhagen,
More informationThe burden of primary headache disorders in Zambia: national estimates from a population-based door-to-door survey
Mbewe et al. The Journal of Headache and Pain (2015) 16:36 DOI 10.1186/s10194-015-0513-9 RESEARCH ARTICLE Open Access The burden of primary headache disorders in Zambia: national estimates from a population-based
More informationCluster headache associated with acute maxillary sinusitis.
Cluster headache associated with acute maxillary sinusitis. Edvardsson, Bengt Published in: SpringerPlus DOI: 10.1186/2193-1801-2-509 2013 Link to publication Citation for published version (APA): Edvardsson,
More informationfrr^.,.^-r{ AL,-*", 3r. ro?dtll 11 'r fnstitute of Neurology & Neurosurgery Korolenko Street no.2, 2O28 Chigindu, Republic of Moldova LLl02/Ls8s
SHORT.STAY SCHOTARSHIP REPORT FORM.2014 Personal details Name Nationality Date of birth Full contact address Current working address Email address Chicu-Hadirca Cristina Republic of Moldova LLl02/Ls8s
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29646 holds various files of this Leiden University dissertation. Author: Dekker, François (Frans) Title: Patients preference in migraine Issue Date: 2014-11-05
More informationChronic Migraine: Epidemiology and Disease Burden
Curr Pain Headache Rep (2011) 15:70 78 DOI 10.1007/s11916-010-0157-z Chronic Migraine: Epidemiology and Disease Burden Aubrey N. Manack & Dawn C. Buse & Richard B. Lipton Published online: 10 November
More informationPrevalence of primary headaches in Germany: results of the German Headache Consortium Study
J Headache Pain (2012) 13:215 223 DOI 10.1007/s10194-012-0425-x ORIGINAL Prevalence of primary headaches in Germany: results of the German Headache Consortium Study M-S Yoon Z. Katsarava M. Obermann G.
More informationPrevalence, management and burden of episodic and chronic headaches a crosssectional multicentre study in eight Austrian headache centres
Zebenholzer et al. The Journal of Headache and Pain (2015) 16:46 DOI 10.1186/s10194-015-0531-7 RESEARCH ARTICLE Open Access Prevalence, management and burden of episodic and chronic headaches a crosssectional
More informationMigranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: June 22, 2017 Migranal Nasal Spray
More informationClinical profile of patients with chronic headache in a tertiary care hospital
International Journal of Advances in Medicine Senthil C et al. Int J Adv Med. 2016 Aug;3(3):721-726 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20162524
More informationTreatment of Intractable Hemicrania Continua by Occipital Nerve Stimulation
Treatment of Intractable Hemicrania Continua by Occipital Nerve Stimulation 1 Sarah Miller MBBS, MRCP 2 Laurence Watkins FRCS, PhD and 1 Manjit Matharu FRCP, PhD 1 Headache Group, Institute of Neurology
More information